FB
FBT.LSE First Trust Global Funds Plc - First Trust Nyse Arca Biotechnology Index Ucits ETF
- GBX
No recent price
- Total assets
- 8.18M
- Expense ratio
- 0.61%
- Dividend yield
- 0.26%
- 1-year return
- +45.18%
- Holdings
- 30
- Since
- 2020
Fund data as reported by the issuer, updated Nov 3, 2026. Total assets are in the fund's base currency.
What does FBT.LSE invest in?
Tracks Morningstar Gbl Biotechnology NR USD- Mostly US stocks (90.3%)
- Largest sector: Healthcare (100.0%)
- Largest region: North America (97.7%)
- Top 3 holdings: 12.7% of the fund
Asset allocation
- US stocks 90.3%
- Non-US stocks 4.8%
- Cash 0.1%
Top holdings
- Genmab AS 4.81%
- Regeneron Pharmaceuticals Inc 4.09%
- Exelixis Inc 3.84%
- Amgen Inc 3.72%
- Biogen Inc 3.72%
First Trust Global Funds Plc - First Trust Nyse Arca Biotechnology Index Ucits ETF performance
Sharpe ratio 1.29- This year
- +32.36%
- 1 year
- +45.18%
- 3 years
- +27.08%
- 5 years
- +10.44%
Volatility 20.0% over 1 year and 16.8% over 3 years. Moderate, similar to a broad stock index.
Total returns in the fund's currency as reported by the issuer; past returns do not predict future returns. Volatility is the yearly standard deviation of returns. Ask AI to explain these numbers
FBT.LSE price
Prices on the chart can differ slightly from the closing prices StockSummer shows.
First Trust Global Funds Plc - First Trust Nyse Arca Biotechnology Index Ucits ETF top holdings
37.7% of the fund| Holding | Sector | Country | Weight |
|---|---|---|---|
| Genmab AS GMAB.US | Healthcare | United States | 4.81% |
| Regeneron Pharmaceuticals Inc REGN.US | Healthcare | United States | 4.09% |
| Exelixis Inc EXEL.US | Healthcare | United States | 3.84% |
| Amgen Inc AMGN.US | Healthcare | United States | 3.72% |
| Biogen Inc BIIB.US | Healthcare | United States | 3.72% |
| Halozyme Therapeutics Inc HALO.US | Healthcare | United States | 3.65% |
| Alkermes Plc ALKS.US | Healthcare | United States | 3.51% |
| TG Therapeutics Inc TGTX.US | Healthcare | United States | 3.51% |
| Gilead Sciences Inc GILD.US | Healthcare | United States | 3.42% |
| Veracyte Inc VCYT.US | Healthcare | United States | 3.40% |
The 10 largest of 30 holdings.
FBT.LSE sector exposure
- Healthcare100.0%
Share of the stocks in the fund.
FBT.LSE regional exposure
- North America97.7%
- Europe Developed4.8%
Share of the stocks in the fund.
Company size
Average market cap 18.9B- Big cap15.6%
- Medium cap29.0%
- Small cap40.3%
- Micro cap13.7%
First Trust Global Funds Plc - First Trust Nyse Arca Biotechnology Index Ucits ETF fund profile
- Fund name
- First Trust Global Funds Plc - First Trust Nyse Arca Biotechnology Index Ucits ETF
- Ticker
- FBT.LSE
- Exchange
- London Exchange
- Index tracked
- Morningstar Gbl Biotechnology NR USD
- Category
- Healthcare Equity
- Domicile
- Ireland
- Inception date
- May 27, 2020
- Trading currency
- GBX
- Expense ratio
- 0.61%